Bayer Advances Radiology Development Portfolio and Fosters Innovation in AI
Bayer moves ahead with the advancement of its comprehensive Radiology portfolio with progress on the development pipeline of new contrast agents as well as further partnerships in its digital business. The company announced today the presentation of new early clinical data for gadoquatrane, Bayer’s novel macrocyclic gadolinium-based compound currently in Phase II development, at the Radiological Society of North America (RSNA) Annual Meeting. 
NHS patients throughout the West Midlands are to benefit from a digital pathology programme, designed to help reduce cancer backlogs, transform services, and improve the speed and accuracy of cancer diagnosis.
Digital speech biomarker company ki:elements has published validation results on the use of its ki:e speech biomarker for cognition (SB-C) in early Alzheimer’s disease in the "Karger - Digital Biomarkers" journal.(1)
Cleveland Clinic and IBM have begun deployment of the first private sector onsite, IBM-managed quantum computer in the United States. The IBM Quantum System is to be located on Cleveland Clinic’s main campus in Cleveland.
UK headquartered healthcare analytics company C2-Ai has appointed a senior clinician as its new medical director international.
Cloud telephony provider X-on has launched Phonebar; an app to consolidate telecoms and patient communications onto the GP desktop.